Literature DB >> 25597757

Interleukin-13 promotes expression of Alix to compromise renal tubular epithelial barrier function.

Chen Xu1, Guangdong Sun, Jie Yang, Qianmei Sun, Zhaohui Tong.   

Abstract

The epithelial barrier dysfunction plays a critical role in a number of kidney diseases. The mechanism is unclear. Alix is a protein involving in protein degradation in epithelial cells. This study aims to investigate that interleukin (IL)-13 inhibits Alix to compromise the kidney epithelial barrier function. In this study, the murine collecting duct cell line (M-1) was cultured in Transwell inserts to investigate the significance of Alix in compromising the epithelial barrier functions. T cell (Teff cells) proliferation assay was employed to assess the antigenicity of ovalbumin (OVA) that was transported across the M-1 monolayer barrier. The results showed that M-1 cells express Alix. Exposure to interleukin (IL)-13 markedly decreased the expression of Alix in M-1 cells, which compromised the M-1 monolayer barrier functions by showing the increases in the permeability to OVA. Over-expression of Alix abolished the IL-13-induced M-1 monolayer barrier dysfunction. Knockdown of Alix significantly increased M-1 monolayer permeability. The OVA collected from the Transwell basal chambers induced the OVA-specific T cell proliferation. We conclude that IL-13 compromises M-1 epithelial barrier functions via inhibiting Alix expression.
© 2015 International Federation for Cell Biology.

Entities:  

Keywords:  barrier function; biological transport; epithelial cells; kidney; renal tubules

Mesh:

Substances:

Year:  2015        PMID: 25597757     DOI: 10.1002/cbin.10433

Source DB:  PubMed          Journal:  Cell Biol Int        ISSN: 1065-6995            Impact factor:   3.612


  1 in total

1.  The role of CDX2 in renal tubular lesions during diabetic kidney disease.

Authors:  Huiming Liu; Rui Yan; Luqun Liang; Huifang Zhang; Jiayi Xiang; Lingling Liu; Xiaohuan Zhang; Yanwen Mao; Wei Peng; Ying Xiao; Fan Zhang; Yuxia Zhou; Mingjun Shi; Yuanyuan Wang; Bing Guo
Journal:  Aging (Albany NY)       Date:  2021-02-17       Impact factor: 5.682

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.